Skip to main content
Top
Published in: Clinical Rheumatology 7/2012

01-07-2012 | Original Article

Hearing and cochlear function of patients with ankylosing spondylitis

Authors: Orhan Kemal Kahveci, Umit Secil Demirdal, Abidin Duran, Ali Altuntas, Vural Kavuncu, Erdogan Okur

Published in: Clinical Rheumatology | Issue 7/2012

Login to get access

Abstract

Ankylosing spondylitis (AS) is a chronic systemic inflammatory disorder that primarily affects the spine and sacroiliac joints. Recent studies described audiovestibular impairment in AS patients. The aim of this study was to evaluate the hearing and function of the cochlear system in patients with AS. Thirty-seven AS patients and 20 healthy controls were evaluated prospectively. Otorhinolaryngologic examinations were performed in all patients together with pure tone audiometry, speech discrimination test, tympanometry, and distortion product otoacoustic emission (DPOE). Disease duration, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores, and hematologic findings (CRP and ESR) were also collected. Pure tone audiometry findings of the patients and controls were significantly different in all frequencies (p < 0.01). Speech discrimination scores were also significantly different (p < 0.01). No significant difference was found between DPOE responses of the patients and controls (p > 0.05). There was no correlation between disease duration, BASDAI scores, hematological findings, and audiometry findings (p > 0.05). This study demonstrated that there is an association between AS and hearing loss, but the cochlea is not the main source of hearing loss.
Literature
1.
go back to reference van der Linden S, van der Heijde D (2000) Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis. Curr Opin Rheumatol 12(4):263–268PubMedCrossRef van der Linden S, van der Heijde D (2000) Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis. Curr Opin Rheumatol 12(4):263–268PubMedCrossRef
2.
go back to reference Zochling J, Smith EU (2010) Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol 24(6):747–756PubMedCrossRef Zochling J, Smith EU (2010) Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol 24(6):747–756PubMedCrossRef
3.
go back to reference El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554–560PubMedCrossRef El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554–560PubMedCrossRef
4.
go back to reference Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR et al (2011) Audiovestibular manifestations in patients with ankylosing spondylitis. Medicine (Baltimore) 90(2):99–109CrossRef Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR et al (2011) Audiovestibular manifestations in patients with ankylosing spondylitis. Medicine (Baltimore) 90(2):99–109CrossRef
5.
go back to reference Casellini C, Citera G, Rosemffet M et al (2005) Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol 11(2):81–85PubMedCrossRef Casellini C, Citera G, Rosemffet M et al (2005) Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol 11(2):81–85PubMedCrossRef
6.
go back to reference Yeo SW, Park SN (2001) Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report. Otolaryngol Head Neck Surg 125(1):113–114PubMedCrossRef Yeo SW, Park SN (2001) Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report. Otolaryngol Head Neck Surg 125(1):113–114PubMedCrossRef
7.
go back to reference Erbek SS, Erbek HS, Yilmaz S et al (2006) Cochleovestibular dysfunction in ankylosing spondylitis. Audiol Neurootol 11(5):294–300PubMedCrossRef Erbek SS, Erbek HS, Yilmaz S et al (2006) Cochleovestibular dysfunction in ankylosing spondylitis. Audiol Neurootol 11(5):294–300PubMedCrossRef
8.
go back to reference Dagli M, Sivas Acar F, Karabulut H, Eryilmaz A, Erkol Inal E (2007) Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 27(6):511–516PubMedCrossRef Dagli M, Sivas Acar F, Karabulut H, Eryilmaz A, Erkol Inal E (2007) Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 27(6):511–516PubMedCrossRef
9.
go back to reference van der Linden SM, Cats A, Valkenburg HA (1988) On the prevalence of ankylosing spondylitis. J Rheumatol 15(2):375–377PubMed van der Linden SM, Cats A, Valkenburg HA (1988) On the prevalence of ankylosing spondylitis. J Rheumatol 15(2):375–377PubMed
10.
go back to reference Scalapino KJ, Davis JC Jr (2003) The treatment of ankylosing spondylitis. Clin Exp Med 2(4):159–165PubMedCrossRef Scalapino KJ, Davis JC Jr (2003) The treatment of ankylosing spondylitis. Clin Exp Med 2(4):159–165PubMedCrossRef
11.
go back to reference Rosenbaum JT (2004) Effect of etanercept on iritis in patients with ankylosing spondylitis. Arthritis Rheum 50(11):3736–3737PubMedCrossRef Rosenbaum JT (2004) Effect of etanercept on iritis in patients with ankylosing spondylitis. Arthritis Rheum 50(11):3736–3737PubMedCrossRef
12.
go back to reference Magarò M, Ceresia G, Frustaci A (1984) Arthritis of the middle ear in ankylosing spondylitis. Ann Rheum Dis 43(4):658–659PubMedCrossRef Magarò M, Ceresia G, Frustaci A (1984) Arthritis of the middle ear in ankylosing spondylitis. Ann Rheum Dis 43(4):658–659PubMedCrossRef
13.
go back to reference De Miguel E, Tomás M, Benito S, Galiván J, Gijón J (1987) Ankylosing spondylitis and middle ear impairment. Ann Rheum Dis 46(2):174PubMedCrossRef De Miguel E, Tomás M, Benito S, Galiván J, Gijón J (1987) Ankylosing spondylitis and middle ear impairment. Ann Rheum Dis 46(2):174PubMedCrossRef
14.
go back to reference Ajodhia JM, Dix MR (1976) Drug-induced deafness and its treatment. Practitioner 216(1295):561–570PubMed Ajodhia JM, Dix MR (1976) Drug-induced deafness and its treatment. Practitioner 216(1295):561–570PubMed
15.
go back to reference Friedmann I (1997) Pathology of the cochlea. In: Kerr AG (ed) Scott Brown’s otolaryngology, vol 3, 6th edn. Butterworth–Heinemann, Oxford, pp 33–34 Friedmann I (1997) Pathology of the cochlea. In: Kerr AG (ed) Scott Brown’s otolaryngology, vol 3, 6th edn. Butterworth–Heinemann, Oxford, pp 33–34
16.
go back to reference Alatas N, Yazgan P, Oztürk A, San I, Iynen I (2005) Audiological findings in patients with ankylosing spondylitis. J Laryngol Otol 119(7):534–539PubMedCrossRef Alatas N, Yazgan P, Oztürk A, San I, Iynen I (2005) Audiological findings in patients with ankylosing spondylitis. J Laryngol Otol 119(7):534–539PubMedCrossRef
17.
go back to reference Samandouras G, Teddy PJ, Cadoux-Hudson T, Ansorge O (2006) Amyloid in neurosurgical and neurological practice. J Clin Neurosci 13(2):159–167PubMedCrossRef Samandouras G, Teddy PJ, Cadoux-Hudson T, Ansorge O (2006) Amyloid in neurosurgical and neurological practice. J Clin Neurosci 13(2):159–167PubMedCrossRef
18.
go back to reference Savastano M, Marioni G, Bernini G, Punzi L (2005) Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment? Acta Otolaryngol 125(6):671–673PubMedCrossRef Savastano M, Marioni G, Bernini G, Punzi L (2005) Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment? Acta Otolaryngol 125(6):671–673PubMedCrossRef
19.
go back to reference Campbell KC, Durrant J (1993) Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am 26(5):903–914PubMed Campbell KC, Durrant J (1993) Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am 26(5):903–914PubMed
Metadata
Title
Hearing and cochlear function of patients with ankylosing spondylitis
Authors
Orhan Kemal Kahveci
Umit Secil Demirdal
Abidin Duran
Ali Altuntas
Vural Kavuncu
Erdogan Okur
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-1984-6

Other articles of this Issue 7/2012

Clinical Rheumatology 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.